المجلة الجزائرية للحقوق والعلوم السياسية
Volume 10, Numéro 2, Pages 1065-1093
2025-12-01
Clinical Trials And Health Risks: How Can The Law Strengthen Participants' Rights In Algeria?
Authors : Abid Abdelmoumen .
Abstract
This paper explains the legal, regulatory, and ethical aspects of clinical trials in Algeria, emphasizing the paramount importance of participant safety and rights over scientific or societal interests, as mandated by national and international regulations. (Chapter I) defines key terminology based on Algerian Health Law No. 18-11 and provides a historical overview of medical research regulations. (Chapter II) discusses potential risks to participants, while (Chapter III) outlines the essential requirements and procedures for clinical trials. Finally, (Chapter IV) focuses on the purpose of good clinical practice in Algerian law, which is to safeguard the well-being, safety, and rights of trial participants.
Keywords
Clinical Trials Regulations ; Human Subjects ; Informed Consent ; Good Clinical Practice (GCP) ; Medical Research Ethics
Les articles similaires
Khellout Souaad
.
pages 182-204.
Djeridi Zohra
.
Merabet Hayet
.
pages 27-31.
